10/19/2005 5:12:51 PM
TOKYO--(BUSINESS WIRE)--Feb. 25, 2005--Daiichi Pharmaceutical Co., Ltd. ("Daiichi") (President and Representative Director, Kiyoshi Morita) and Sankyo Co., Ltd. ("Sankyo") (President and Representative Director, Takashi Shoda) announced today they have concluded a basic agreement to integrate their businesses commencing October 2005. Resolutions by the Boards of both companies approved this agreement earlier today.
Kiyoshi Morita, President and CEO of Daiichi commented, "The integration of our two businesses will enable us to achieve a level of growth and a range of opportunities that would be out of our reach individually."
comments powered by